The results show that anti-miR-21 decreased the expression of CD44 and EpCAM in MiaPaCa-2 tumor sphere cells under hypoxic conditions, consistent with the results from CDF treatment (Figure 4B). This evidence concerns the gene CD44 and neoplasm.